Atropos Health

The latest study on ChatRWD™ beta has shown that it surpasses Big Tech LLMs in physician trust and the ability to provide complete answers with high-quality evidence. The results, published in a preprint on arXiv, highlight ChatRWD's superiority in delivering reliable and accurate real-world evidence for healthcare. LLMs have increasingly been considered as potential sources of evidence, summarizing information from prior literature learned during LLM training. While LLMs have displayed impressive performance in responding to natural language queries in various medical domains, they are prone to hallucinating reference materials or treatment guidelines and may produce “recommendations” that are inappropriate. Atropos Health tested ChatRWD beta, OpenEvidence, and three “out-of-the-box” LLMs (ChatGPT-4, Claude 3 Opus, and Gemini Pro version 1.5) to answer the same clinical questions context of care delivery. Key Findings: ChatRWD beta outperformed other LLMs with a remarkable 94% completion rate. Independent physician reviewers found ChatRWD beta to provide the best answer to 60% of the questions. Read the full paper to see more results at arXiv. Atropos Health's Chief Medical Officer and co-founder, Dr. Saurabh Gombar, emphasized the importance of rigorously measuring and verifying the reliability of AI technologies in healthcare. ChatRWD's ability to generate evidence for both well-studied and novel questions sets it apart. “Built on the core technology GENEVA OS™ (Generative Evidence Acceleration Operating System), ChatRWD is not tied to any single LLM ,” said Neil Sanghavi, President of Atropos Health. “GENEVA OS is deployed locally...and it does not expose any patient-level clinical or claims data to LLMs; the LLMs in ChatRWD are used to create the query and design the study, but GENEVA OS is used to execute the query - without any connection to the LLMs.” The full launch of ChatRWD is on the horizon, promising to democratize access to transparent, reliable, and personalized real-world evidence for all. Read more and sign-up for the ChatRWD beta program at https://hubs.ly/Q02F0Kvk0 #AtroposHealth #ChatRWD #RealWorldEvidence #HealthcareInnovation #AIinMedicine #LLM #LargeLanguageModels

Join us on July 10 at Amazon Web Services (AWS) Summit New York

The Atropos Evidence Network has grown to over 300 million patients, making it the industry's largest federated healthcare data network. We welcome two new partners and new customer Translational Drug Development (TD2) in our efforts to drive the scale of evidence generation needed to enable personalized evidence for everyone. Atropos Health is committed to providing real world evidence for healthcare decision-making. The Atropos Evidence Network operates on GENEVA OS™ (Generative Evidence Acceleration Operating System), a federated model, forming secure, cloud-based connections between healthcare data proprietors and clinical insight seekers across the healthcare ecosystem. De-identified data doesn’t change hands - reducing data security and identity management risks. Forian Inc. provides a unique suite of data management capabilities and proprietary information and analytics solutions to optimize and measure operational, clinical and financial performance for customers within the traditional and emerging life sciences and healthcare payer and provider segments. Syndesis Health is the data and technology catalyst to a multi-continent network of healthcare and life sciences organizations. These partners bring extensive, diverse and high-quality datasets to the Atropos Evidence Network. TD2 is a leader in precision oncology, providing innovative services for improved drug development. TD2 will leverage the Atropos Evidence Network to improve patient outcomes, develop protocols, and clinical trial evidence in oncology. This collaboration will accelerate the development of new therapies and bring them to patients with greater precision and speed. Learn more : https://hubs.li/Q02C--dJ0 #AtroposHealth #HealthcareData #AtroposEvidenceNetwork #PrecisionMedicine #RealWorldData #PatientOutcomes #realworldevidence #RWE #RWD

It's essential to demand robust evidence for healthcare decision-making and transparency into the methods that generate that evidence. #AtroposHealth Chief Medical Officer and co-founder Dr. Saurabh Gombar, an expert in the field, recently penned an insightful op-ed in STAT about the dangers of blindly trusting AI and analytic tools in healthcare. He highlights the need for proper statistical methods for evidence generation when it comes to treatment recommendations. It's crucial for tech companies to uphold the same standards of evidence as pharma companies do for #FDA approval. Let's ensure that care recommendations are based on evidence using sound methodology.  #HealthTech #EvidenceBasedMedicine #PatientCare #HealthcareInnovation #MedicalResearch #DataAnalytics #realworldevidence #decisionsupport #healthcareinnovation

New partnership announcement: Atropos Health has partnered with Norstella to expand the Atropos Evidence™ Network and Structured Clinical Trial Intelligence. This collaboration brings together cutting-edge AI technologies with global data to accelerate innovation for life science. With Norstella's extensive reach and Atropos Health's innovative Generative AI platform, GENEVA OS™, healthcare and life science leaders will have access to advanced evidence-generation tools that will enhance access to democratized federated healthcare data and speed to evidence generation and rapid insights. The combined expertise and solution offerings in real-world evidence between Atropos Health and Norstella are paving the way for faster, more efficient clinical research design, feasibility, and recruitment. Atropos Health will leverage Norstella's extensive reach, including companies such as Panalgo, Citeline, Evaluate, MMIT, and The Dedham Group to improve the quality, accuracy, and efficiency of evidence for their customers and accelerate the pathway to increased adoption of the practice of evidence-based medicine. Thanks to Mike Gallup, Kevin McCurry, Alice Jeffers, Dr. Brigham Hyde, and Kris Karson for bringing our teams together. Read more here: https://hubs.li/Q02C2p7y0 #HealthcareInnovation #EvidenceGeneration #ClinicalTrials #AtroposHealth #Norstella #GENEVAOS #AI #LifeSciences #RWE #Realworldevidence

With Arcadia, we share a commitment to transform healthcare through data-driven insights. The goal of our partnership is to improve value-based care delivery and empower modern healthcare organizations with real-world evidence (RWE) for decision making. https://lnkd.in/eg4jNK6w #HealthcareInnovation #EvidenceGeneration #ValueBasedCare #AtroposHealth #Arcadia #RealWorldEvidence #generativeAI

Thank you #DHISEAST for hosting a great event in Boston this week! The "Can Digital Health Reduce the Costs of Drugs?" panel with Atropos Health co-Founder and CEO Dr. Brigham Hyde, Carrie Williams from McKesson Ventures and Lynne Nowak, MD, from Surescripts and facilitator Ian Chiang from Flare Capital Partners was a compelling conversation on the digital health revolution. Learn more about how Atropos Health is working with Life Science companies: https://hubs.li/Q02B0BKV0 #AtroposHealth #DigitalHealth #RealWorldEvidence #RWE

Learn more about how the clinicians leveraged Atropos Health and real world evidence (#RWE) here: https://lnkd.in/eJ9SQimk

What a week! Thanks to all of our customers, colleagues, friends, media partners, @nasdaq and others for the messages on our company news. As Dr. Hyde said: "Much more to come" Check out our full list of media coverage here: https://lnkd.in/eEfQFiCE

Friday Vendor Shout-out: Red Summit Productions As a young company trying to do something new, telling your story is critical. Right now that has to be Video. Michael Krentzman and team were an amazing choice. They run the whole shoot, full suite production, incredibly professional, editing, scripting, animation, and very strong on look-feel and technical. For #pharma #agency folks they have been the behind the scenes on a number of major patient and provider based campaigns, and if you are annoyed with your current vendors please give them a look. DM me or Michael Krentzman for intro or capabilities deck.